SYT11 and Parkinson disease: The role of palmitoylation in a pathological context has been shown in Parkinson’s disease, with the accumulation of α-synuclein as a downstream effect of the palmitoylation of vesicle-trafficking protein Synaptotagmin-11 (Syt11) [23].